Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Non-steroidal anti-inflammatory drugs Stories

2009-10-21 07:00:00

BETHESDA, Md. and CHICAGO, Oct. 21 /PRNewswire/ -- The American Gastroenterological Association (AGA) and Horizon Therapeutics, Inc. today announced the expansion of their partnership program, Connect to Protect (connecttoprotect.com) to include components that educate consumers about the gastrointestinal (GI) risks associated with chronic non-steroidal anti-inflammatory drug (NSAID) use and ways to manage those risks. "Studies show that patients often under-report the use of...

2009-10-20 08:25:00

WALTHAM, Mass., Oct. 20 /PRNewswire-USNewswire/ -- Logical Therapeutics, Inc. (Logical), a biopharmaceutical company focused on developing products that treat medical conditions associated with inflammation, has been selected to present the results of its clinical study comparing the gastrointestinal (GI) safety of its lead product LT-NS001, vs. naproxen at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009. LT-NS001 is the first in a new...

2009-10-19 10:43:00

NASHVILLE, Tenn., Oct. 19 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six...

2009-10-19 08:01:00

PHILADELPHIA, Oct. 19 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) and POZEN Inc. (Nasdaq: POZN) today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA. The data demonstrated that patients at risk for developing NSAID-associated gastric ulcers taking VIMOVO(TM) (naproxen/esomeprazole magnesium, formerly known as PN 400) experienced significantly fewer...

d86cc8fb1a7ab151991ee4d00126758e
2009-10-11 07:30:00

Children treated for arm fractures with ibuprofen had their pain reduced just as effectively as a combination of acetaminophen and codeine (Tylenol 3), with fewer adverse effects, in a randomized, double-blind trial. The study tested ibuprofen, sold as Advil, Motrin and other brands, against acetaminophen plus codeine "” a combo called Tylenol No. 3 that is also sold in generic form. "The children on ibuprofen did better," said the study leader, Dr. Amy Drendel of the Medical College...

2009-10-06 07:30:00

SAN DIEGO, Oct. 6 /PRNewswire/ -- Accumetrics, Inc., developer and marketer of the VerifyNow® System, the first rapid and easy-to-use diagnostic system for measuring an individual's response to multiple antiplatelet agents, announced today that it has completed a round of financing that will raise $16.5 million in new capital. The capital infusion, which will fully finance the company into 2011, came from the company's existing investors, including Arnerich Massena,...

2009-10-06 06:30:00

LA JOLLA, Calif., Oct. 6 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower...

2009-10-05 06:30:00

NASHVILLE, Tenn., Oct. 5 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009. Data from the following clinical trials of Caldolor will be...

2009-09-25 09:07:07

Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested. The results were presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the...

2009-09-22 06:48:07

Research to be presented in November at the 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition While most women experience minor pain during menstruation, for others, the pain can be severe enough to interfere with everyday activities and require medication. New research to be presented at the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition will reveal initial findings of safety surrounding a new device that may...